203 related articles for article (PubMed ID: 11798949)
21. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
25. [Effect of astaxanthin on vascular smooth muscle cells proliferation induced by platelet derived growth factor-BB].
Gong F; Zhao F; Yao SY; Gan XD
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2031-5. PubMed ID: 27470964
[TBL] [Abstract][Full Text] [Related]
26. [Effects of human tissue kallikrein gene delivery on the proliferation of vascular smooth muscle cells].
Zhu PL; Yu HZ; Xie LD; Ruan JM; Xu CS; Li TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):739-44. PubMed ID: 21055144
[TBL] [Abstract][Full Text] [Related]
27. [The role of AT1 receptor and cyclin kinase inhibitor p27 protein in angiotensin II-induced hypertrophy of mesangial cell].
Mei X; Gao C; Cui R
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):609-12. PubMed ID: 11758242
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
[TBL] [Abstract][Full Text] [Related]
29. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.
Chang MW; Barr E; Lu MM; Barton K; Leiden JM
J Clin Invest; 1995 Nov; 96(5):2260-8. PubMed ID: 7593612
[TBL] [Abstract][Full Text] [Related]
32. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
[TBL] [Abstract][Full Text] [Related]
33. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.
Campos AH; Wang W; Pollman MJ; Gibbons GH
Circ Res; 2002 Nov; 91(11):999-1006. PubMed ID: 12456485
[TBL] [Abstract][Full Text] [Related]
34. Hesperetin, a bioflavonoid, inhibits rat aortic vascular smooth muscle cells proliferation by arresting cell cycle.
Jin YR; Han XH; Zhang YH; Lee JJ; Lim Y; Kim TJ; Yoo HS; Yun YP
J Cell Biochem; 2008 May; 104(1):1-14. PubMed ID: 17979132
[TBL] [Abstract][Full Text] [Related]
35. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells.
Sakakibara K; Kubota K; Worku B; Ryer EJ; Miller JP; Koff A; Kent KC; Liu B
J Biol Chem; 2005 Jul; 280(27):25470-7. PubMed ID: 15894805
[TBL] [Abstract][Full Text] [Related]
36. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
37. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia.
Abid MR; Yano K; Guo S; Patel VI; Shrikhande G; Spokes KC; Ferran C; Aird WC
J Biol Chem; 2005 Aug; 280(33):29864-73. PubMed ID: 15961397
[TBL] [Abstract][Full Text] [Related]
38. JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations.
Seo JM; Jin YR; Ryu CK; Kim TJ; Han XH; Hong JT; Yoo HS; Lee CK; Yun YP
Biochem Pharmacol; 2008 Mar; 75(6):1331-40. PubMed ID: 18191105
[TBL] [Abstract][Full Text] [Related]
39. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
Liu X; Cheng Y; Zhang S; Lin Y; Yang J; Zhang C
Circ Res; 2009 Feb; 104(4):476-87. PubMed ID: 19150885
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
